183 related articles for article (PubMed ID: 25304095)
1. Insulin resistance in adolescents with Turner syndrome is comparable to obese peers, but the overall metabolic risk is lower due to unknown mechanism.
Wojcik M; Janus D; Zygmunt-Gorska A; Starzyk JB
J Endocrinol Invest; 2015 Mar; 38(3):345-9. PubMed ID: 25304095
[TBL] [Abstract][Full Text] [Related]
2. The correlation between serum adipokines levels and metabolic indicators in girls with Turner syndrome.
Zhang Y; Chen RM; Lin XQ; Yuan X; Yang XH
Cytokine; 2019 Jan; 113():139-143. PubMed ID: 29983357
[TBL] [Abstract][Full Text] [Related]
3. Prepubertal ultra-low-dose estrogen therapy is associated with healthier lipid profile than conventional estrogen replacement for pubertal induction in adolescent girls with Turner syndrome: preliminary results.
Ruszala A; Wojcik M; Zygmunt-Gorska A; Janus D; Wojtys J; Starzyk JB
J Endocrinol Invest; 2017 Aug; 40(8):875-879. PubMed ID: 28397183
[TBL] [Abstract][Full Text] [Related]
4. The association of FGF23 levels in obese adolescents with insulin sensitivity.
Wojcik M; Janus D; Dolezal-Oltarzewska K; Drozdz D; Sztefko K; Starzyk JB
J Pediatr Endocrinol Metab; 2012; 25(7-8):687-90. PubMed ID: 23155694
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of early cardiometabolic risk factors in children and adolescents with Turner syndrome.
O'Gorman CS; Syme C; Lang J; Bradley TJ; Wells GD; Hamilton JK
Clin Endocrinol (Oxf); 2013 Jun; 78(6):907-13. PubMed ID: 23106295
[TBL] [Abstract][Full Text] [Related]
6. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
[TBL] [Abstract][Full Text] [Related]
7. FGF23 contributes to insulin sensitivity in obese adolescents - preliminary results.
Wojcik M; Dolezal-Oltarzewska K; Janus D; Drozdz D; Sztefko K; Starzyk JB
Clin Endocrinol (Oxf); 2012 Oct; 77(4):537-40. PubMed ID: 22103239
[TBL] [Abstract][Full Text] [Related]
8. Serum FGF21 in girls with anorexia nervosa - comparison to normal weight and obese female adolescents.
Mikolajczak A; Oswiecimska JM; Swietochowska E; Roczniak W; Ziora KT
Neuro Endocrinol Lett; 2017 Jul; 38(3):173-181. PubMed ID: 28759185
[TBL] [Abstract][Full Text] [Related]
9. Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome.
Van Pareren YK; De Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Drop SL
J Clin Endocrinol Metab; 2002 Dec; 87(12):5442-8. PubMed ID: 12466334
[TBL] [Abstract][Full Text] [Related]
10. [Situation of impaired glucose regulation and metabolic syndrome in overweight or obesity adolescent students in Dongguan city].
Peng YQ; Nie WM; Chen JG; Tang HM; Cao T; Lin YX
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jun; 43(6):495-500. PubMed ID: 19950716
[TBL] [Abstract][Full Text] [Related]
11. Metabolic and cardiovascular outcomes in a group of adult patients with Turner's syndrome under hormonal replacement therapy.
Giordano R; Forno D; Lanfranco F; Manieri C; Ghizzoni L; Ghigo E
Eur J Endocrinol; 2011 May; 164(5):819-26. PubMed ID: 21378088
[TBL] [Abstract][Full Text] [Related]
12. [Metformin hydrochloride ameliorates adiponectin levels and insulin sensitivity in adolescents with metabolic syndrome].
Liang L; Fu JF; Zou CC; Hong F; Wang CL; Wang XM
Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):118-21. PubMed ID: 16624028
[TBL] [Abstract][Full Text] [Related]
13. Low insulin-like growth factor 1 is associated with low high-density lipoprotein cholesterol and metabolic syndrome in Chinese nondiabetic obese children and adolescents: a cross-sectional study.
Liang S; Hu Y; Liu C; Qi J; Li G
Lipids Health Dis; 2016 Jun; 15():112. PubMed ID: 27343122
[TBL] [Abstract][Full Text] [Related]
14. Growth Hormone Treatment Increases Plasma Irisin Concentration in Patients with Turner Syndrome.
Wikiera B; Zawadzka K; Łaczmański Ł; Słoka N; Bolanowski M; Basiak A; Noczyńska A; Daroszewski J
Horm Metab Res; 2017 Feb; 49(2):122-128. PubMed ID: 27926952
[TBL] [Abstract][Full Text] [Related]
15. Klotho and fibroblast growth factors 19 and 21 serum concentrations in children and adolescents with normal body weight and obesity and their associations with metabolic parameters.
Socha-Banasiak A; Michalak A; Pacześ K; Gaj Z; Fendler W; Socha A; Głowacka E; Kapka K; Gołąbek V; Czkwianianc E
BMC Pediatr; 2020 Jun; 20(1):294. PubMed ID: 32546231
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of GH-treated girls with Turner syndrome: metabolic consequences.
Bannink EM; van der Palen RL; Mulder PG; de Muinck Keizer-Schrama SM
Horm Res; 2009; 71(6):343-9. PubMed ID: 19506392
[TBL] [Abstract][Full Text] [Related]
17. Is obesity-related insulin status the cause of blunted growth hormone secretion in Turner's syndrome?
Vaccaro F; Cianfarani S; Pasquino AM; Boscherini B
Metabolism; 1995 Aug; 44(8):1033-7. PubMed ID: 7637644
[TBL] [Abstract][Full Text] [Related]
18. The relationship of periaortic fat thickness and cardiovascular risk factors in children with Turner syndrome.
Akyürek N; Atabek ME; Eklioglu BS; Alp H
Pediatr Cardiol; 2015 Jun; 36(5):925-9. PubMed ID: 25601134
[TBL] [Abstract][Full Text] [Related]
19. Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome.
Wooten N; Bakalov VK; Hill S; Bondy CA
J Clin Endocrinol Metab; 2008 Jun; 93(6):2109-14. PubMed ID: 18349057
[TBL] [Abstract][Full Text] [Related]
20. Components of the metabolic syndrome in girls with Turner syndrome treated with growth hormone in a long term prospective study.
Błaszczyk E; Shulhai AM; Gieburowska J; Barański K; Gawlik AM
Front Endocrinol (Lausanne); 2023; 14():1216464. PubMed ID: 37497348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
